Neurologic & Analgesic Drugs PNLE Questions
Introduction
The live published inventory contains exactly 20 original Tangerine PNLE-style practice questions for Neurologic & Analgesic Drugs. This topic belongs to NP7, Pharmacology, and covers seizure, migraine, Parkinson, anesthesia, and analgesic medications. The questions are practice items for learning clinical reasoning; they are not official PNLE questions, recalled items, or a promise of what will appear on an exam.
Use this lens to connect medication knowledge with nursing decisions: identify the intended effect, recognize toxicity, account for renal or neurologic findings, protect the airway, prioritize urgent assessment, and teach safe medication use. Psychiatric and substance-use medications are outside this scope and belong in Psychotropic & Addiction Drugs. Autonomic Drugs and Musculoskeletal & Inflammatory Drugs are adjacent practice areas, so check the medication purpose before assigning a question to one topic.
The 2025 Enhanced TOS places official exam planning within broad competencies across the five-subject PNLE TOS. Neurologic & Analgesic Drugs is a Tangerine pedagogical lens mapped across relevant competencies, not a separate official test subject. The official TOS does not assign a guaranteed weight to this microtopic, and exact microtopic distribution varies by exam form.
Key concepts
- Protect ventilation during opioid therapy
Recognize: Increasing sleepiness, difficult arousal, shallow or slowed breathing, and reduced responsiveness are safety cues, especially after a dose change or in a patient with kidney disease.
Decide: Assess airway, breathing, oxygenation, and level of consciousness; withhold further doses when indicated and escalate according to the order set or facility protocol.
Avoid: Treating sedation as an adequate measure of pain relief or waiting for complete unresponsiveness before acting. - Adjust the analgesic decision to renal status
Recognize: Chronic kidney disease can change medication handling and increase the risk of accumulation or adverse effects, even when the pain is severe.
Decide: Review the prescribed drug, dose, interval, renal information, hydration status, and current response before administration; monitor both relief and toxicity.
Avoid: Assuming that a usual adult regimen is automatically safe or independently changing a dose without an authorized plan. - Balance seizure control with antiepileptic toxicity surveillance
Recognize: Breakthrough seizures, missed doses, unusual lethargy, confusion, persistent vomiting, abdominal symptoms, or abnormal bleeding findings require focused assessment and prompt communication.
Decide: Confirm adherence and prescribed administration, apply seizure precautions, assess the patient, and report concerning findings for ordered evaluation.
Avoid: Telling a patient to stop antiseizure therapy abruptly or dismissing a serious adverse-effect cue as ordinary tiredness. - Give Parkinson medication with functional safety in mind
Recognize: Bradykinesia, rigidity, changes in mobility, orthostatic symptoms, and involuntary movements help distinguish response, inadequate control, and adverse effects during levodopa therapy.
Decide: Administer consistently as prescribed, assess mobility and fall risk, and relate changes to medication timing when reporting findings.
Avoid: Giving doses whenever convenient, overlooking unsafe ambulation, or presenting levodopa as a cure rather than symptom-directed therapy. - Screen the headache before giving migraine medication
Recognize: The reported pattern, associated symptoms, onset, prior response, and any new neurologic change guide whether a routine migraine plan is appropriate.
Decide: Complete focused assessment first, follow the prescribed medication plan, and escalate sudden or atypical findings for further evaluation.
Avoid: Labeling every headache as migraine, repeating doses without checking the plan, or allowing medication use to replace assessment. - Separate sedation from airway protection during anesthesia
Recognize: Midazolam-related memory impairment and sedation may coexist with impaired safety awareness or respiratory compromise; anesthetic care also requires attention to airway and recovery status.
Decide: Verify readiness within the nursing role, maintain ordered monitoring, protect the patient from falls, and reassess airway, breathing, consciousness, and recovery before routine activity.
Avoid: Equating sleep with stable ventilation or assuming amnesia means the patient can be left without appropriate observation. - Match analgesic therapy to the pain problem
Recognize: Pain cause, quality, severity, functional impact, and whether a medication is intended for immediate relief, baseline control, or an adjuvant role determine the nursing assessment.
Decide: Clarify the therapeutic goal, assess response and adverse effects, and evaluate the whole prescribed plan rather than one drug in isolation.
Avoid: Expecting every analgesic or adjuvant to work immediately, duplicating therapy, or judging effectiveness only by a single pain score.
What to expect on the PNLE
The live inventory contains 20 questions: 5 easy, 8 medium, and 7 hard. Its Bloom distribution is 7 remembering, 2 understanding, 5 applying, 2 analyzing, and 4 evaluating, so preparation should include both factual retrieval and patient-safety judgment. These figures describe the published Tangerine inventory, not a guaranteed pattern for an official exam form.
Supported question forms include mechanism or intended-effect recall, adverse-effect recognition, medication teaching, priority nursing action, and selection of the safest response when renal, respiratory, neurologic, or recovery findings modify the situation. Several forms require the learner to connect a drug cue with an immediate nursing priority rather than identify a definition alone.
- Remembering: Retrieve drug purposes, mechanisms, and characteristic safety concerns for seizure, migraine, Parkinson, anesthesia, and analgesic medications.
- Applying: Use the patient’s assessment findings to choose monitoring, teaching, administration, or escalation actions.
- Analyzing: Separate expected therapeutic effects from toxicity and distinguish a routine symptom pattern from a concerning change.
- Evaluating: Rank competing actions by airway protection, neurologic safety, renal risk, and the need for prompt reassessment.
Exact topic distribution varies by exam form. Prepare across the full canonical scope and use the inventory to diagnose reasoning gaps, not to predict a microtopic count.
Study tips
- Begin with diagnostic practice. Complete the 20-question inventory without opening notes. Mark each answer as confident, guessed, or missed, then sort the result by seizure, migraine, Parkinson, anesthesia, and analgesic decisions.
- Use focused retrieval. For each weak area, close the reference material and write the drug purpose, priority assessment, dangerous finding, teaching point, and escalation action. Include a boundary note that separates this topic from Psychotropic & Addiction Drugs.
- Review rationales and errors. For every item, explain why the correct option fits the clinical cue and why each distractor is unsafe, incomplete, or aimed at the wrong priority. Label the error as knowledge, cue recognition, prioritization, or medication-safety reasoning.
- Build a comparison table for active recall. Make columns for drug or class, target problem, intended effect, danger cue, and first nursing response. Fill rows for an opioid, an antiepileptic, levodopa, a migraine medication, an anesthetic or sedative, and an analgesic adjuvant, then cover the entries and retrieve them again.
- Retry, then mix and time. Rework missed questions after a later study session without looking at the rationale first. Finish with mixed questions from adjacent pharmacology areas under a consistent time limit, giving priority to airway, breathing, neurologic change, renal risk, and patient safety.
Common mistakes to avoid
- Calling opioid-induced hypoventilation ordinary sleepiness. The correcting cue is the breathing pattern and level of arousal, not the patient’s report of comfort. Airway and breathing assessment take priority over documenting pain relief or giving another dose.
- Ignoring kidney disease when reviewing analgesics. Severe pain does not remove the need to check renal status and the prescribed plan. The safety principle is to verify medication handling, dose instructions, monitoring, and response rather than inventing an adjustment.
- Stopping antiseizure medication abruptly or overlooking toxicity. Missed therapy can contribute to loss of seizure control, while marked lethargy, confusion, gastrointestinal symptoms, or bleeding findings may require prompt evaluation. Follow authorized instructions and report concerning findings.
- Judging levodopa only by whether tremor improves. Mobility, rigidity, orthostatic symptoms, involuntary movements, and fall risk are also nursing data. Link the finding to administration timing and protect the patient during movement.
- Giving routine migraine medication for every headache. A new pattern, sudden onset, altered consciousness, or focal neurologic change changes the priority from routine symptom treatment to focused assessment and escalation.
- Assuming anesthetic sedation equals safe recovery. Memory impairment does not confirm adequate ventilation or safe ambulation. Continue the ordered airway, breathing, consciousness, and fall-safety checks before allowing routine activity.
Try a question
A real Neurologic & Analgesic Drugs question from our bank. Give it a shot.
A nurse is providing care for a patient who has a prescription for dextroamphetamine (Dexedrine) 25 mg PO daily. The nurse collaborates with the dietician to limit the amount of which option items on the patient’s dietary trays?
Dextroamphetamine (Dexedrine) is a central nervous system (CNS) stimulant commonly prescribed for attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. It acts primarily by increasing the levels of dopamine and norepinephrine in the brain, resulting in heightened alertness and focus. However, one of the key nursing implications when caring for patients taking CNS stimulants such as dextroamphetamine is the need to manage interactions that can potentiate adverse effects.
Caffeine is another CNS stimulant found in coffee, tea, chocolate, sodas, and some over-the-counter medications. Consuming caffeine alongside dextroamphetamine can lead to an additive effect, significantly increasing the risk of CNS stimulation. This includes heightened effects such as tachycardia (increased heart rate), hypertension, insomnia, nervousness, and in rare cases, cardiac arrhythmias or even seizures. Because both substances stimulate similar pathways, their concurrent use increases the patient's risk of toxicity and side effects. Therefore, it is a standard nursing intervention to limit or restrict caffeine intake in patients receiving dextroamphetamine in order to minimize these risks and promote patient safety.
| Option | Rationale |
|---|---|
| A. Starch | Starch is a carbohydrate and does not interact with dextroamphetamine, nor does it influence its absorption or effects. It is not a dietary concern with this medication. |
| B. Protein | Diets high in protein can occasionally alter drug absorption, but protein does not have a significant stimulatory effect that interacts with dextroamphetamine. No specific limitation is needed. |
| C. Caffeine | Caffeine is a stimulant that, when combined with dextroamphetamine, can increase the risk of excessive CNS stimulation and side effects. Caffeine restriction is necessary to prevent additive stimulant effects. |
| D. Fat | Dietary fat does not directly interact with dextroamphetamine’s pharmacodynamics or expected side effects. No evidence suggests limiting fat with stimulant medications for safety. |
Nurses must demonstrate clinical reasoning by anticipating interactions and engaging in collaboration with dietitians to promote patient safety. Recognizing which substances potentiate side effects of medications is an essential component of safe pharmacological management.
Clinical pearls:
- Remember: "Double the stimulant, double the trouble." Combining two stimulants enhances side effects.
- Teach patients to check labels on beverages and even over-the-counter medicines for hidden caffeine.
When in doubt, always prioritize interventions that minimize synergistic side effects and ensure patient comfort and safety.
- Videbeck, S. L. (2011). Psychiatric-Mental Health Nursing (5th ed.). Lippincott Williams & Wilkins.
More Neurologic & Analgesic Drugs questions
20 questions available. Sign up to practice all of them.
An opioid-treated patient is sleepier but arousable; respirations are 8/min and shallow while SpO₂ remains 95% on oxygen. Which interpretation best reconciles the findings?
A patient has pain 8/10, RR 10/min, marked sedation, CKD, and orders for IV morphine plus acetaminophen. Which action is safest?
A nonpregnant adult with renal colic is vomiting, eGFR 82, and has no ulcer, bleeding, or NSAID allergy. IV acetaminophen failed. Which prescribed drug should the nurse give next?
References and further reading
- PRC Enhanced Table of Specifications for the Nurses Licensure Examination official
The current public competency and cognitive-level blueprint, effective from the November 2025 NLE onward. - Tangerine Prep PNLE Reviewer question bank
The live source for the published question count, question previews, rationales, and inventory distributions on this page.
How this page is built
The counts and distributions on this page come from Tangerine Prep's live published question bank. The source inventory was last updated on August 12, 2026.
The questions are original PNLE-style practice items, not recalled or leaked board questions. Topic scope follows Tangerine's pedagogical taxonomy and is mapped to the PRC 2025 Enhanced Table of Specifications, effective from the November 2025 NLE onward. Exact topic distribution varies by exam form.